cimetidine has been researched along with Hyperprolactinaemia in 2 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Excerpt | Relevance | Reference |
---|---|---|
"Levosulpiride/Cimetidine treatment induced mild hyperprolactinaemia that was associated with NKC activation and Th1-type cytokine profile." | 3.91 | Prolactin Induces IL-2 Associated TRAIL Expression on Natural Killer Cells from Chronic Hepatitis C Patients ( Bernal, AR; Cordova, J; Garcia, AP; Hernández, J; Kershenobich, D; Luna, JS; Medel, MLH; Mummidi, S; Parra, A; Porras, LM; Reyes, GG, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Medel, MLH | 1 |
Reyes, GG | 1 |
Porras, LM | 1 |
Bernal, AR | 1 |
Luna, JS | 1 |
Garcia, AP | 1 |
Cordova, J | 1 |
Parra, A | 1 |
Mummidi, S | 1 |
Kershenobich, D | 1 |
Hernández, J | 1 |
Adashi, EY | 1 |
Katz, E | 1 |
1 review available for cimetidine and Hyperprolactinaemia
Article | Year |
---|---|
Diagnostic work-up of hyperprolactinemic disorders.
Topics: Antipsychotic Agents; Cimetidine; Estrogens; Female; Humans; Hyperprolactinemia; Hypothyroidism; Mag | 1988 |
1 other study available for cimetidine and Hyperprolactinaemia
Article | Year |
---|---|
Prolactin Induces IL-2 Associated TRAIL Expression on Natural Killer Cells from Chronic Hepatitis C Patients
Topics: Cells, Cultured; Cimetidine; Gene Expression; Hepatitis C, Chronic; Humans; Hyperprolactinemia; Inte | 2019 |